Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Comparative evaluation of hepatitis C virus RNA quantitation by branched DNA, NASBA, and monitor assays.

Hepatology (Baltimore, Md.) - 1 Feb 1999

Lunel F, Cresta P, Vitour D, Payan C, Dumont B, Frangeul L, Reboul D, Brault C, Piette J C, Huraux J M

Abstract excerpt

Several studies have shown a relationship between pretreatment hepatitis C virus (HCV) viral load and the response to interferon (IFN) therapy, creating a need for quantitative HCV-RNA assays. Here, we compared three commercial methods: nucleic acid sequence-based amplification NASBA (Organon), branched DNA 2.0 (bDNA) (Chiron), and Monitor (Roche), with reverse-transcription polymerase chain reaction (RT-PCR) as...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Base Sequence
Share to DNA
Share to Gene Amplification

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genotype

Share to Hepacivirus

Share to Hepatitis C

Share to RNA, Viral

Share to Sensitivity and Specificity

Source

Identifiers

PMID: 9918931
DOI: 10.1002/hep.510290237

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Comparative evaluation of hepatitis C virus RNA quantitation by branched DNA, NASBA, and monitor assays.PMID 9918931Read ↗

Characterization of the quantitative HCV NASBA assay.Semantic proximity Read ↗

Quantification of hepatitis C virus RNA in serum by branched DNA-based signal amplification assays.Semantic proximity Read ↗

Quantitation of hepatitis C virus RNA by third generation branched DNA-based signal amplification assay.Semantic proximity Read ↗

Quantification of hepatitis C virus RNA by RT-PCR in comparison to the branched DNA method.Semantic proximity Read ↗

Comparison of real-time quantitative polymerase chain reaction with three other assays for quantitation of hepatitis C virus.Semantic proximity Read ↗

Accurate quantification of hepatitis C virus (HCV) RNA from all HCV genotypes by using branched-DNA technology.Semantic proximity Read ↗

Quantitative measurement of serum HCV RNA in patients with chronic hepatitis C: comparison between Amplicor HCV monitor system and branched DNA signal amplification assay.Semantic proximity Read ↗

Clinical evaluation of the branched DNA assay for hepatitis B virus DNA detection in patients with chronic hepatitis B lacking hepatitis B e antigen and treated with interferon-alpha.Semantic proximity Read ↗

Comparison of 3 quantitative HCV RNA assays--accuracy of baseline viral load to predict treatment outcome in chronic hepatitis C.Semantic proximity Read ↗

Evaluation of quantitative measurements of hepatitis C virus RNA to predict sustained response to interferon by genotype.Semantic proximity Read ↗

Performance characteristics of a real-time RT-PCR assay for quantification of hepatitis C virus RNA in patients with genotype 1 and 2 infections.Semantic proximity Read ↗

Hepatitis C virus RNA levels determined by branched DNA probe assay correlated with levels assessed using competitive PCR.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.